|
|
|
Volumn 320, Issue 7247, 2000, Pages 1475-1476
|
|
Cost utility of drugs for multiple sclerosis. Analysis goes too far.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
IMMUNOLOGICAL ADJUVANT;
INTERFERON BETA SERINE;
INTERFERON BETA-1B;
HEALTH CARE ORGANIZATION;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
QUALITY ADJUSTED LIFE YEAR;
ADJUVANTS, IMMUNOLOGIC;
HEALTH CARE RATIONING;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
QUALITY-ADJUSTED LIFE YEARS;
|
|
EID: 0034720417
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
